Brief: Boryung Pharm Agrees To Terminate $70 Mln Worth Contract With Novartis' Unit In Southeast Asia
26/08/2019 08:18
Aug 26 (Reuters) - Boryung Pharm Co Ltd 003850.KS :
* AGREES TO TERMINATE 85 BILLION WON ($70.09 million) WORTH
CONTRACT WITH NOVARTIS' UNIT IN SOUTHEAST ASIA
Source text for Eikon: https://bit.ly/2NwTDEF
Further company coverage: 003850.KS
($1 = 1,212.6600 won)
((sangmi.cha.thomsonreuters.com@reuters.net;))
Recent news on Boryung
See all newsBrief: Boryung Corp Q1 Operating Profit 20.2 Billion Won, Up 84.7% From Year Earlier
Brief: Boryung Corp Q4 Operating Profit 20 Billion Won, Up 36% From Year Earlier
Brief: Boryung Corp Q2 Operating Profit 25.4 Billion Won, Up 26% From Year Earlier
Brief: Boryung Q1 Operating Profit 11 Billion Won, Down 33% From Year Earlier
Brief: Boryung Corp Q4 Operating Profit 14.6 Billion Won, Down 1.5% From Year Earlier